U.S. Patent Disclosures
Tuesday, August 14, 2012
Neuralstem Inc., of Rockville, Md., has been issued U.S. Patent No. 12/710,097, "Transplantation of Human Neural Cells for Treatment of Neurodegenerative Conditions." The patent covers the process of culturing central nervous system cells and transplanting them into spinal cord tissue to treat neurodegenerative disorders, such as amytrophic lateral sclerosis.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.